Details for Patent: 11,344,520
✉ Email this page to a colleague
Which drugs does patent 11,344,520 protect, and when does it expire?
Patent 11,344,520 protects LICART and is included in one NDA.
Summary for Patent: 11,344,520
| Title: | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug |
| Abstract: | The present invention provides for a method of improving the release of non-steroidal anti-inflammatory drugs (NSAIDs) from a plaster or bandage comprising an adhesive layer with a pharmaceutically acceptable NSAID together with heparin or a heparinoid. The invention also provides for methods of reducing muscle hyperalgesia in subjects without spontaneous pain. |
| Inventor(s): | Frangione; Valeria (Lugano, CH), Lanzarotti; Arturo (Lugano, CH) |
| Assignee: | ALTERGON SA (Lugano, CH) |
| Application Number: | 17/322,151 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,344,520
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibsa Inst Bio | LICART | diclofenac epolamine | SYSTEM;TOPICAL | 206976-001 | Dec 19, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ACUTE PAIN DUE TO MINOR STRAINS, SPRAINS, AND CONTUSIONS USING A DICLOFENAC PATCH CONTAINING HEPARIN FOR ONCE DAILY ADMINISTRATION WHERE HEPARIN IS NOT RELEASED | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
